Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, indicating a small underlying update to the page. This change does not alter visible content or user-facing functionality.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the recruitment status now indicates no participants are being sought. The Intervention/Treatment heading was updated and the revision tag bumped from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check29 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a small update to the page metadata; no study data or eligibility criteria are affected.SummaryDifference0.0%

- Check51 days agoChange DetectedA new 'Sample Collection' item was added and the page revision updated to v3.5.4; the previous version v3.5.3 was removed.SummaryDifference0.2%

- Check72 days agoChange DetectedUpdates the ClinicalTrials.gov page’s displayed revision identifier (e.g., version v3.5.2 to v3.5.3), reflecting a site/software release rather than a change to the trial record.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a new release entry on 2026-04-13 with Revision: v3.5.2, replacing the previous Revision: v3.5.0 dated 2026-04-08.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.